{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-042193","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.349598+00:00","generated_at":"2026-05-30T11:02:06.585455+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Daré Bioscience awarded $10M from ARPA-H to develop HPV treatment candidate DARE-HPV","bullets":["Award of $10M from ARPA-H Sprint for Women's Health; milestone-based payments over 24 months.","DARE-HPV: investigational fixed-dose lopinavir/ritonavir vaginal insert for HPV-related cervical diseases.","Milestones include IND-enabling studies, FDA IND clearance, clinical supplies, and Phase 2 trial start.","More than half of award payable in first 12 months; ARPA-H retains certain IP rights including march-in."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-042193","json":"https://secwatch.observer/filing/0001493152-24-042193.json","markdown":"https://secwatch.observer/filing/0001493152-24-042193.md","text":"https://secwatch.observer/filing/0001493152-24-042193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224042193/0001493152-24-042193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224042193/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:02:06.585455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}